Levodopa and psoriasis.
Levodopa administered orally in doses of two to four grams daily for up to eight weeks had no apparent therapeutic effect on psoriatic lesions in eleven patients with severe nummular psoriasis.
D000328:Adult; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy*
D007980:Levodopa